statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	29.107
EU - Europa	15.074
AS - Asia	8.652
SA - Sud America	1.339
AF - Africa	123
Continente sconosciuto - Info sul continente non disponibili	37
OC - Oceania	15
Totale	54.347

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	28.825
IT - Italia	7.102
SG - Singapore	3.021
UA - Ucraina	2.295
TR - Turchia	1.649
HK - Hong Kong	1.262
SE - Svezia	1.226
DE - Germania	1.169
CN - Cina	1.160
BR - Brasile	1.129
VN - Vietnam	1.038
IE - Irlanda	802
FI - Finlandia	687
GB - Regno Unito	641
RU - Federazione Russa	499
FR - Francia	224
CA - Canada	160
IN - India	151
MX - Messico	96
JP - Giappone	82
AR - Argentina	81
NL - Olanda	76
PL - Polonia	68
AT - Austria	61
BD - Bangladesh	61
ES - Italia	60
ZA - Sudafrica	53
IQ - Iraq	37
LT - Lituania	36
BE - Belgio	34
EU - Europa	29
EC - Ecuador	26
CL - Cile	22
MA - Marocco	22
CZ - Repubblica Ceca	20
IL - Israele	20
PK - Pakistan	20
ID - Indonesia	19
VE - Venezuela	19
CO - Colombia	17
PY - Paraguay	17
UZ - Uzbekistan	17
AE - Emirati Arabi Uniti	14
AU - Australia	14
KE - Kenya	13
SA - Arabia Saudita	13
CH - Svizzera	11
JO - Giordania	11
PE - Perù	11
UY - Uruguay	11
EG - Egitto	10
IR - Iran	10
PT - Portogallo	9
RO - Romania	9
AZ - Azerbaigian	8
GR - Grecia	8
MY - Malesia	7
PH - Filippine	7
AL - Albania	6
BO - Bolivia	6
CI - Costa d'Avorio	6
RS - Serbia	6
DZ - Algeria	5
HN - Honduras	5
LB - Libano	5
TW - Taiwan	5
DO - Repubblica Dominicana	4
HU - Ungheria	4
KR - Corea	4
KW - Kuwait	4
KZ - Kazakistan	4
OM - Oman	4
TH - Thailandia	4
TT - Trinidad e Tobago	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
DK - Danimarca	3
ET - Etiopia	3
MK - Macedonia	3
NG - Nigeria	3
NO - Norvegia	3
NP - Nepal	3
AM - Armenia	2
AO - Angola	2
BA - Bosnia-Erzegovina	2
BY - Bielorussia	2
CR - Costa Rica	2
DM - Dominica	2
GT - Guatemala	2
JM - Giamaica	2
LI - Liechtenstein	2
LK - Sri Lanka	2
MD - Moldavia	2
PA - Panama	2
PS - Palestinian Territory	2
SI - Slovenia	2
SN - Senegal	2
SV - El Salvador	2
TN - Tunisia	2
A1 - Anonimo	1
Totale	54.335

Salva come PNG Salva come JPEG

Città	#
Milan	5.039
Fairfield	4.108
Woodbridge	2.671
Ashburn	2.461
Houston	1.948
Jacksonville	1.808
Singapore	1.655
Seattle	1.609
Wilmington	1.505
Chandler	1.387
Cambridge	1.385
Ann Arbor	1.312
Hong Kong	1.257
Dallas	866
Izmir	815
Dublin	796
Princeton	787
Dearborn	591
Nyköping	539
Boardman	502
Beijing	412
The Dalles	384
Dong Ket	367
Rome	330
Munich	300
Los Angeles	260
San Diego	244
Chicago	236
New York	214
London	192
Helsinki	167
San Mateo	159
Ogden	152
São Paulo	128
Como	127
Santa Clara	123
Ho Chi Minh City	119
Washington	105
Nuremberg	75
Düsseldorf	71
Tokyo	70
Montreal	65
Hefei	63
Redmond	62
Hanoi	60
Nanjing	59
Buffalo	57
Turku	55
Warsaw	55
Norwalk	53
Verona	53
Kunming	52
Mexico City	52
Brooklyn	51
Salt Lake City	47
Denver	45
Phoenix	44
Chennai	43
Frankfurt am Main	41
Stockholm	41
Atlanta	40
Paris	40
Toronto	40
Kocaeli	39
Orem	38
Boston	37
Rio de Janeiro	37
Council Bluffs	36
Johannesburg	36
San Francisco	36
Varese	36
Belo Horizonte	33
Amsterdam	30
Jinan	30
Kilburn	30
Poplar	30
Brussels	29
Columbus	27
Tampa	27
Guangzhou	25
Manchester	25
Elk Grove Village	24
Nanchang	24
Vienna	22
Besana In Brianza	20
Falkenstein	20
San Jose	20
Ankara	19
Falls Church	19
Mumbai	19
Ponte Lambro	19
Redwood City	19
Philadelphia	18
Prescot	18
Fuzhou	17
Haiphong	17
Miami	17
Shenyang	17
Brasília	16
Chiswick	16
Totale	39.336

Salva come PNG Salva come JPEG

Nome	#
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	360
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	321
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	301
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	295
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	280
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	261
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	247
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	232
Risk of recurrence of unusual site venous thromboembolism	231
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	231
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	231
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	228
ABO blood group and vascular disease: an update	228
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	223
Optimal treatment duration of venous thrombosis	221
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	221
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	214
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	213
Venous ischemic syndromes	213
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	212
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	211
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	211
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	209
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	208
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	208
Patient selection for thromboprophylaxis in medical inpatients	207
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	204
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	202
Warfarin interactions with antibiotics in the ambulatory care setting	200
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	199
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	198
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	197
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	196
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	196
Venous and arterial thrombosis in patients with HIV infection	194
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	194
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	193
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	192
Abdominal obesity and the risk of recurrent deep vein thrombosis.	190
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	190
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	190
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	189
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	188
Seasonal and monthly variation in occurrence of hypertensive urgency	188
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	188
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	187
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	187
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	187
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	186
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	185
sRAGE and early signs of cardiac target organ damage in mild hypertensives	185
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	184
Duration of anticoagulation after venous thromboembolism in real world clinical practice	184
Statins and secondary prevention of ischemic and hemorrhagic stroke	183
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	183
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	181
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	178
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	177
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	177
Statins for acute ischemic stroke	177
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	176
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	176
Is diabetes a hypercoagulable state? A critical appraisal	176
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	176
Statins, fibrates, and venous thromboembolism: a meta-analysis.	175
In vitro effects of Apixaban on 5 different cancer cell lines	175
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	174
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	173
5 flourouracil-induced apical ballooning syndrome: a case report.	172
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	172
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	172
Italian intersociety consensus on DOAC use in internal medicine	172
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	172
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	171
The role of thrombolytic therapy in pulmonary embolism	171
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	170
Prevention of in-hospital VTE: why can't we do better?	170
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	170
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	170
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	169
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	169
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	169
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	169
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	169
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.	168
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	168
How I treat splanchnic vein thrombosis	168
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect?	168
The effect of thyroid autoantibodies on warfarin stability	168
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	167
External validation of the DASH prediction rule: a retrospective cohort study	167
PM10 exposure is associated with increased hospitalizations for respiratory syncytial virus bronchiolitis among infants in Lombardy, Italy	166
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	165
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	165
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	164
Brand name versus generic warfarin: a systematic review of the literature.	162
Management of hypertension in overweight and obese patients: a practical guide for clinicians.	162
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	162
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis	162
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	162
Totale	19.418

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	249.009
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	249.009

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4.388	0	0	0	0	0	732	291	619	838	458	574	876
2021/2022	4.033	403	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	7.080	1.049	1.000	917	1.983	1.355	776	0	0	0	0	0	0
Totale													54.885